We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

A New Way to Treat Type 1 and Type 2 Diabetes?

News   Nov 01, 2018 | Original story from the University of Helsinki

 
A New Way to Treat Type 1 and Type 2 Diabetes?

Islets of Langerhans containing MANF-expressing β-cells (red) contain more insulin-containing β-cells (green) (A) than those that lack MANF-expressing β-cells (B). Credit: MARIA LINDAHL

 
 
Advertisement
 

RELATED ARTICLES

Targeting the Circadian Rhythm Regulator CRY-1 in Prostate Cancer

News

A regulator of circadian rhythms, known as CRY-1 has been shown to promote tumor progression by altering DNA repair.

READ MORE

Enzyme in Tumor Cells Could Be Used To Monitor Cancer Treatment

News

Researchers are studying the possibility of inhibiting a protein known as low molecular weight protein tyrosine phosphatase (LMWPTP) to create novel opportunities for monitoring and treatment of cancer and other diseases.

READ MORE

Inhibiting Glutamine Metabolism Could Be an Effective Therapeutic Strategy for ARID1A-Mutant Ovarian Cancer

News

According to a new study, mutations that inactivate the ARID1A gene in ovarian cancer increase utilization of the glutamine amino acid making cancer cells dependent on glutamine metabolism. The researchers also demonstrated that pharmacologic inhibition of glutamine metabolism could be an effective strategy for treating ARID1A-mutant ovarian cancer.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE